Huadong Medicine Co Ltd
Research Huadong Medicine Co Ltd (000963.SZ) on Bullrun: market cap CNY 46.04B, P/E 13.3, dividend yield 3.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker000963.SZ
- ExchangeSZ
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCNY
- Market capCNY 46.04B
- P/E13.3
- Dividend yield3.5%
- Financial periodQ2 2026
- RevenueCNY 10.88B
- Net incomeCNY 858.57M
- Free cash flowCNY 2.90B
- Gross margin31.6%
Valuation Snapshot
latest market cap is CNY 46.04B; P/E is 13.3; dividend yield is 3.5%.
Peer valuation comparison
Latest P/E is 13.26x versus a Healthcare sector median of 21.75x (39.0% below).
Latest dividend yield is 3.54% versus a Healthcare sector median of 2.4% (47.5% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | CNY 46.04B | 13.3 | 3.5% | 0.93 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.93 CNY, yield 3.5%.
About Huadong Medicine Co Ltd
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Huadong Medicine Co Ltd's market cap?
Huadong Medicine Co Ltd's market capitalization is CNY 46.04B.
What is Huadong Medicine Co Ltd's P/E ratio?
Huadong Medicine Co Ltd's price-to-earnings (P/E) ratio is 13.3.
Does Huadong Medicine Co Ltd pay a dividend?
Huadong Medicine Co Ltd has a dividend yield of 3.5%.
What does Huadong Medicine Co Ltd do?
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments. It offers Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty field, and medical devices, as well as engages in pharmaceutical logistics and industrial microbiology activities.